JNBA Financial Advisors - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 166 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2015. The put-call ratio across all filers is 1.89 and the average weighting 0.5%.

Quarter-by-quarter ownership
JNBA Financial Advisors ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2021$1,0000.0%5500.0%0.00%
Q3 2021$1,0000.0%5500.0%0.00%
Q2 2021$1,000
-50.0%
5500.0%0.00%
Q1 2021$2,000
+100.0%
5500.0%0.00%
Q4 2020$1,0000.0%5500.0%0.00%
Q3 2020$1,000
-50.0%
5500.0%0.00%
Q2 2020$2,000
+100.0%
5500.0%0.00%
Q1 2020$1,000
-66.7%
5500.0%0.00%
-100.0%
Q4 2019$3,000
+50.0%
5500.0%0.00%
Q3 2019$2,000
-33.3%
5500.0%0.00%
-100.0%
Q2 2019$3,000
+50.0%
5500.0%0.00%
Q1 2019$2,000
+100.0%
5500.0%0.00%
Q4 2018$1,000
-50.0%
5500.0%0.00%
Q2 2018$2,0000.0%5500.0%0.00%
Q1 2018$2,0000.0%5500.0%0.00%
Q4 2017$2,000
-33.3%
5500.0%0.00%
-100.0%
Q3 2017$3,0000.0%5500.0%0.00%0.0%
Q2 2017$3,0000.0%5500.0%0.00%0.0%
Q1 2017$3,0000.0%5500.0%0.00%0.0%
Q4 2016$3,000
-62.5%
550
-63.3%
0.00%0.0%
Q3 2016$8,000
+166.7%
1,500
+172.7%
0.00%0.0%
Q2 2016$3,000
-25.0%
5500.0%0.00%0.0%
Q1 2016$4,000
-20.0%
5500.0%0.00%
-50.0%
Q4 2015$5,0000.0%5500.0%0.00%0.0%
Q3 2015$5,000
-28.6%
5500.0%0.00%
-33.3%
Q2 2015$7,0005500.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2015
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$60,394,0003.07%
MSD Partners, L.P. 3,410,500$21,213,0001.32%
MILLER VALUE PARTNERS, LLC 4,926,456$30,643,0001.24%
Michael & Susan Dell Foundation 66,749$415,0000.33%
ACUTA CAPITAL PARTNERS, LLC 150,000$933,0000.26%
Piermont Capital Management Inc. 85,500$532,0000.15%
A.R.T. Advisors, LLC 411,547$2,559,0000.14%
EQUITEC PROPRIETARY MARKETS, LLC 96,100$598,0000.14%
Vident Investment Advisory, LLC 204,744$1,274,0000.10%
EQUITEC PROPRIETARY MARKETS, LLC 68,800$428,0000.10%
View complete list of ZIOPHARM ONCOLOGY INC shareholders